Lausanne, Switzerland, September 19th, 2018 – Oculis, a clinical-stage biotechnology companydeveloping next-generation topical treatments for acute and chronic back-...
Lausanne, Switzerland, January 4th, 2017, Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough non-invasive...
Prof. Stefansson, Oculis co-founder, was awarded Peter Watson prize and chair of Cambridge Ophthalmological symposium at the 47th Symposium of...
Lausanne, Switzerland, January 4th, 2017, Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough...
Lausanne, Switzerland, January 4th, 2017, Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough non-invasive topical treatment for back-of-the-eye...